Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-23-020349

Chairman and CEO gave up 37,205 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2023-03-18 Shares withheld for taxes −37,205 $1.92 $71,434 5,716,153 D
Loading xslF345X04/doc4.xml…